<?xml version="1.0" encoding="UTF-8"?>
<p>Animal models used in the evaluation of the formulation treatment efficacy were male Sprague-Dawley rats (6–8 weeks, 200–220 g) supplied by Animal Supply Unit, Pharos University in Alexandria, Alexandria, Egypt. The study protocol was approved by the Unit of Research Ethics on Animal Experimentation of Pharos University in Alexandria (file no. 3025/2019-10). Animal care in the facility complies with the ‘Principles of Laboratory Animal Care’ by the American Society for Medical Research and the ‘Guide for the Care and Use of Laboratory Animals’ by NIH (Bethesda, MD).</p>
